Get FREE SHIPPING when you spend $99 or more | ATOMFAIR

Awaiting product image

Atomfair N-(3-chloro-4-fluorophenyl)-7-fluoro-6-nitroquinazolin-4-amine C14H7ClF2N4O2 CAS 162012-67-1

N-(3-chloro-4-fluorophenyl)-7-fluoro-6-nitroquinazolin-4-amine (CAS No. 162012-67-1) is a high-purity quinazoline derivative designed for advanced research applications. This compound features a molecular formula of C14H7ClF2N4O2and a molecular weight of 336.68 g/mol, with a unique nitro-fluoro substitution pattern that enhances its reactivity and binding affinity. Its structural complexity makes it an ideal candidate for pharmaceutical development, particularly in kinase inhibition studies and targeted cancer therapies. The product is rigorously tested for purity (≥95% by HPLC) and stability, ensuring reliable performance in sensitive assays. Available in milligram to gram quantities, it is supplied in amber vials under inert atmosphere to prevent degradation.

Category:

Description

N-(3-chloro-4-fluorophenyl)-7-fluoro-6-nitroquinazolin-4-amine (CAS No. 162012-67-1) is a high-purity quinazoline derivative designed for advanced research applications. This compound features a molecular formula of C14H7ClF2N4O2 and a molecular weight of 336.68 g/mol, with a unique nitro-fluoro substitution pattern that enhances its reactivity and binding affinity. Its structural complexity makes it an ideal candidate for pharmaceutical development, particularly in kinase inhibition studies and targeted cancer therapies. The product is rigorously tested for purity (≥95% by HPLC) and stability, ensuring reliable performance in sensitive assays. Available in milligram to gram quantities, it is supplied in amber vials under inert atmosphere to prevent degradation.

Properties

  • CAS Number: 162012-67-1
  • Complexity: 441
  • IUPAC Name: N-(3-chloro-4-fluoro-phenyl)-7-fluoro-6-nitro-quinazolin-4-amine
  • InChI: InChI=1S/C14H7ClF2N4O2/c15-9-3-7(1-2-10(9)16)20-14-8-4-13(21(22)23)11(17)5-12(8)18-6-19-14/h1-6H,(H,18,19,20)
  • InChI Key: CJOJDNRJDBWZKM-UHFFFAOYSA-N
  • Exact Mass: 336.0225595
  • Molecular Formula: C14H7ClF2N4O2
  • Molecular Weight: 336.68
  • SMILES: C1=CC(=C(C=C1NC2=NC=NC3=CC(=C(C=C32)[N+](=O)[O-])F)Cl)F
  • Topological: 83.6
  • Monoisotopic Mass: 336.0225595
  • Synonyms: 162012-67-1, N-(3-chloro-4-fluorophenyl)-7-fluoro-6-nitroquinazolin-4-amine, DTXSID60442902, DTXCID60393723, 808-276-1, 4-QUINAZOLINAMINE, N-(3-CHLORO-4-FLUOROPHENYL)-7-FLUORO-6-NITRO-, 4-(3-Chloro-4-fluorophenylamino)-7-fluoro-6-nitroquninazoline, MFCD09998825, N-(3-chloro-4-fluorophenyl)-7-fluoro-6-nitro-4-quinazolinamine, 4-[(3-chloro-4-fluorophenyl)amino]-7-fluoro-6-nitroquinazoline, (3-Chloro-4-fluoro-phenyl)-(7-fluoro-6-nitro-quinazolin-4-yl)-amine, C14H7ClF2N4O2, 4-(3-CHLORO-4-FLUOROPHENYLAMINO)-7-FLUORO-6-NITROQUINAZOLINE, CJOJDNRJDBWZKM-UHFFFAOYSA-N, N-(3-Chloro-4-fluorophenyl)-7-fluoro-6-nitro-4-quinazolinamine; (3-Chloro-4-fluorophenyl)(7-fluoro-6-nitroquinazolin-4-yl)amine, N-(3-chloro-4-fluoro-phenyl)-7-fluoro-6-nitro-quinazolin-4-amine, SCHEMBL25241, BCP08568, CS-M0991, AKOS015917847, AKOS034830279, PB34506, AC-27054, AS-11445, SY028080, A3594, C3276, 4-(3-chloro-4-fluorophenyl)amino-6-nitro-7-fluoroquinazoline, 6-nitro-4-(3-chloro-4-fluorophenylamino)-7-fluoro-quinazoline, 4-[(3-chloro-4-fluoro-phenyl)amino]-7-fluoro-6-nitro-quinazoline, 4-[(3-chloro-4-fluorophenyl)amino]-6-nitro-7-fluoro-quinazoline, 4-[(3-chloro-4-fluorophenyl)amino]-6-nitro-7-fluoroquinazoline, 4-[N-(3-Chloro-4-fluorophenyl)amino]-7-fluoro-6-nitroquinazoline, 4-Quinazolinamine,N-(3-chloro-4-fluorophenyl)-7-fluoro-6-nitro-, N-(3-chloro-4-fluorophenyl)-7-fluoro-6-nitroquinazoline-4-amine, (3-Chloro-4-fluoro-phenyl)-(7-fluoro-6-nitro-quinazoline-4-yl)-amine, (3-CHLORO-4-FLUOROPHENYL)(7-FLUORO-6-NITROQUINAZOLIN-4-YL)AMINE, 4-(3-CHLORO-4-FIUORO-PHENYLAMINO)-7-FLUORO-6-NITROQUNINAZOLINE, 4-(3-CHLORO-4-FLUORO-PHENYLAMINO)-7-FLUORO-6-NITROQUNINAZOLINE

Application

N-(3-chloro-4-fluorophenyl)-7-fluoro-6-nitroquinazolin-4-amine is primarily utilized in medicinal chemistry as a key intermediate for synthesizing EGFR (Epidermal Growth Factor Receptor) inhibitors. Researchers employ this compound to investigate structure-activity relationships in tyrosine kinase inhibition, particularly for non-small cell lung cancer (NSCLC) therapeutics. Its nitro group allows for further functionalization via reduction or nucleophilic substitution, enabling diversification of quinazoline-based drug candidates.

Safety and Hazards

GHS Hazard Statements

  • Not Classified
  • Reported as not meeting GHS hazard criteria by 1 of 1 companies. For more detailed information, please visit ECHA C&L website.

Hazard Classes and Categories

  • Not Classified

If you are interested or have any questions, please contact us at support@atomfair.com

Disclaimer: Sold exclusively for laboratory research. Prohibited for commercial use, diagnostics, or human/animal applications. Buyers assume all compliance liability.

Disclaimer

Intended Use & Restrictions

This product is sold exclusively for laboratory research, analytical testing, or non-commercial purposes.

  • Strictly prohibited: Resale, repackaging, or formulation into commercial products.
  • Not approved for human/animal use, diagnostics, or manufacturing (including pharmaceuticals, agrochemicals, or consumer goods).

Patent & Regulatory Compliance

Certain molecules may be protected by active patents or regulatory restrictions.

  • Buyers must independently verify patent status (e.g., via USPTO/EPO/CNIPA) and comply with local laws.
  • Atomfair LLC does not provide legal assurances regarding patent non-infringement or jurisdictional compliance.

Liability Release

By purchasing, the buyer agrees to:

  • Use this product only as permitted by law.
  • Indemnify Atomfair LLC against all claims arising from misuse, patent infringement, or regulatory violations.

Reviews

There are no reviews yet.

Only logged in customers who have purchased this product may leave a review.

Related products